Izhar T.
Novalgin in pain and fever.
J Pak Med Assoc Jan ;49(9):226-7.

OBJECTIVE: Efficacy, tolerability and safety of Dipyrone (Novalgin) in the management of pain and fever in children. SETTING: Open, non-comparative study in Ganga Ram Hospital, Lahore. SUBJECTS: Children (of both sexes) aged 3 months to 12 years with oral temperature of 38.5 degrees C or more/complaining of pain due to various reasons. RESULTS: Sixty-two (66.7%) out of 93 who had fever showed good response, 24 (25.8%) showed satisfactory response and 7 (7.5%) showed unsatisfactory response to Dipyrone (Novalgin). CONCLUSION: Dipyrone (Novalgin) in a dose of 10-15 mg/kg/dose every 6-8 hrs. is effective and safe in the treatment of pain and fever in children.

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com